As a result of the increased TCRγδ in the CD3+-CD8+ group, T lymphocytes are capable of producing abundant proinflammatory cytokines such as IFN-γ, powerful cytotoxic effector functions, and MHC-independent recognition of antigens, making them an essential component of cancer immunotherapy [49]. This evidence concerns the gene HLA-C and cancer.